These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 17239838

  • 1. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C, Wetterö J.
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, Dayer JM, Roux-Lombard P, Fontao L, Kallenberg CG, Bijl M, Matthias T, Fraser A, Zandman-Goddard G, Blank M, Gilburd B, Meroni PL.
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
    Tan Y, Yu F, Yang H, Chen M, Fang Q, Zhao MH.
    Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
    [Abstract] [Full Text] [Related]

  • 5. Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.
    Wetterö J, Nilsson L, Jonasson L, Sjöwall C.
    Clin Chim Acta; 2009 Feb; 400(1-2):128-31. PubMed ID: 18973750
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C, Bengtsson AA, Sturfelt G, Skogh T.
    Arthritis Res Ther; 2004 Feb; 6(2):R87-94. PubMed ID: 15059271
    [Abstract] [Full Text] [Related]

  • 7. Biological markers in inflammatory rheumatic diseases.
    Hilliquin P.
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):993-1006. PubMed ID: 8747080
    [Abstract] [Full Text] [Related]

  • 8. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D.
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [Abstract] [Full Text] [Related]

  • 9. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
    Bijl M, Bootsma H, Van Der Geld Y, Limburg PC, Kallenberg CG, Van Rijswijk MH.
    Ann Rheum Dis; 2004 Jul; 63(7):831-5. PubMed ID: 15194579
    [Abstract] [Full Text] [Related]

  • 10. C-reactive protein and the acute phase response.
    Gewurz H, Mold C, Siegel J, Fiedel B.
    Adv Intern Med; 1982 Jul; 27():345-72. PubMed ID: 7041546
    [Abstract] [Full Text] [Related]

  • 11. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U.
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 13. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus.
    Seelen MA, van der Bijl EA, Trouw LA, Zuiverloon TC, Munoz JR, Fallaux-van den Houten FC, Schlagwein N, Daha MR, Huizinga TW, Roos A.
    Rheumatology (Oxford); 2005 Jan; 44(1):111-9. PubMed ID: 15479757
    [Abstract] [Full Text] [Related]

  • 14. Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus.
    Augusto JF, Onno C, Blanchard S, Dubuquoi S, Mantovani A, Chevailler A, Jeannin P, Subra JF.
    Rheumatology (Oxford); 2009 Apr; 48(4):442-4. PubMed ID: 19213851
    [No Abstract] [Full Text] [Related]

  • 15. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M.
    J Immunol; 2009 Sep 01; 183(5):3512-21. PubMed ID: 19648280
    [Abstract] [Full Text] [Related]

  • 16. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
    Kristjansdottir H, Saevarsdottir S, Gröndal G, Alarcón-Riquelme ME, Erlendsson K, Valdimarsson H, Steinsson K.
    Arthritis Rheum; 2008 Dec 01; 58(12):3865-72. PubMed ID: 19035512
    [Abstract] [Full Text] [Related]

  • 17. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T, Tengvall P.
    Biochem Biophys Res Commun; 2007 Jan 05; 352(1):251-8. PubMed ID: 17113035
    [Abstract] [Full Text] [Related]

  • 18. C-Reactive protein and its implications in systemic lupus erythematosus.
    de Carvalho JF, Hanaoka B, Szyper-Kravitz M, Shoenfeld Y.
    Acta Reumatol Port; 2007 Jan 05; 32(4):317-22. PubMed ID: 18159197
    [Abstract] [Full Text] [Related]

  • 19. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R, Daha MR.
    Mol Immunol; 2007 Jan 05; 44(1-3):133-8. PubMed ID: 16870257
    [Abstract] [Full Text] [Related]

  • 20. Antibody to serum amyloid A.
    Rosenau BJ, Schur PH.
    J Autoimmun; 2004 Sep 05; 23(2):179-82. PubMed ID: 15324936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.